HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inokosterone Is A Potential Drug Target of Estrogen Receptor 1 in Rheumatoid Arthritis Patients: Analysis from Active Ingredient of Cyathula Officinalis.

AbstractOBJECTIVE:
To elucidate the active compounds and the molecular mechanism of Cyathula Officinalis as a drug treatment for rheumatoid arthritis (RA).
METHODS:
The target genes of active ingredients from Cyathula Officinalis were obtained from bioinformatics analysis tool for the molecular mechanism of traditional Chinese medicine. The protein-protein interaction between the target genes were analyzed using STRING and Genemania. The transcriptome of RA patients compared to healthy people (GSE121894) were analyzed using R program package Limma. The relative expression of the target genes was obtained from the RNA-seq datasets. The molecular docking analyses were processed based on the molecular model of estrogen receptor 1 (ESR1) binding with estradiol (PDB ID:1A52). The binding details were analyzed by SYBYL.
RESULTS:
Inokosterone, ecdysterone, and cyaterone were the 3 active ingredients from Cyathula Officinalis that bind to target genes. Of all the significantly changed genes from RA patients, ESR1, ADORA1, and ANXA1 were significantly increased in mRNA samples of RA patients.
CONCLUSION:
ESR1, the transcription factor that binds inokosterone in the molecular binding analysis, is the target protein of Cyathula Officinalis.
AuthorsJi-Hao Mo, Han-Kun Xie, Ye-Mian Zhou, Sihan-Benjamin Ng, Shao-Xia Li, Lei Wang
JournalChinese journal of integrative medicine (Chin J Integr Med) Vol. 27 Issue 10 Pg. 767-773 (Oct 2021) ISSN: 1672-0415 [Print] China
PMID34432202 (Publication Type: Journal Article)
Copyright© 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.
Chemical References
  • Cholestenes
  • Estrogen Receptor alpha
  • Pharmaceutical Preparations
  • inokosterone
Topics
  • Arthritis, Rheumatoid (drug therapy, genetics)
  • Cholestenes
  • Estrogen Receptor alpha
  • Humans
  • Molecular Docking Simulation
  • Pharmaceutical Preparations

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: